Results
1375
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1375 companies
Tilray Brands
Market Cap: US$1.4b
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.
TLRY
US$1.19
7D
-5.6%
1Y
-31.6%
Novavax
Market Cap: US$1.4b
A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.
NVAX
US$8.34
7D
-2.2%
1Y
-31.3%
North China Pharmaceutical Company.Ltd
Market Cap: CN¥10.0b
Engages in the research and development, production, and sales of pharmaceutical products in China.
600812
CN¥5.80
7D
-2.0%
1Y
12.8%
PeptiDream
Market Cap: JP¥208.0b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,615.50
7D
-2.4%
1Y
-40.6%
Shanghai Runda Medical Technology
Market Cap: CN¥9.9b
Shanghai Runda Medical Technology Co., Ltd.
603108
CN¥16.01
7D
-3.9%
1Y
-0.4%
Janux Therapeutics
Market Cap: US$1.4b
A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.
JANX
US$21.77
7D
-10.8%
1Y
-53.3%
Zhejiang Xianju PharmaceuticalLtd
Market Cap: CN¥9.8b
Manufactures and sells steroids and hormones worldwide.
002332
CN¥9.84
7D
-1.9%
1Y
-21.2%
Azenta
Market Cap: US$1.4b
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
AZTA
US$28.75
7D
-7.4%
1Y
-41.5%
PharmaBlock Sciences (Nanjing)
Market Cap: CN¥9.5b
Provides chemistry products and services throughout the pharmaceutical research and development, and commercial production.
300725
CN¥40.68
7D
-2.1%
1Y
29.1%
Chengdu Kanghua Biological Products
Market Cap: CN¥9.5b
Chengdu Kanghua Biological Products Co., Ltd.
300841
CN¥77.28
7D
1.2%
1Y
40.2%
ST PharmLtd
Market Cap: ₩1.9t
Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
A237690
₩88,900.00
7D
-5.4%
1Y
-11.2%
Arcus Biosciences
Market Cap: US$1.3b
A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
RCUS
US$12.37
7D
-0.6%
1Y
-19.6%
Tianjin Ringpu Bio-TechnologyLtd
Market Cap: CN¥9.4b
Engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.
300119
CN¥20.93
7D
-4.6%
1Y
55.4%
Alivus Life Sciences
Market Cap: ₹116.1b
Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.
ALIVUS
₹939.20
7D
-10.3%
1Y
-8.8%
Blue Jet Healthcare
Market Cap: ₹115.3b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹645.90
7D
-4.9%
1Y
25.4%
Shandong Xinhua Pharmaceutical
Market Cap: HK$10.1b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$7.16
7D
-3.2%
1Y
25.4%
Syndax Pharmaceuticals
Market Cap: US$1.3b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$15.03
7D
-2.7%
1Y
-17.2%
Cisen Pharmaceutical
Market Cap: CN¥9.2b
Research, develops, produces, and sells drug products in China and internationally.
603367
CN¥19.84
7D
-5.0%
1Y
47.9%
Sanofi India
Market Cap: ₹112.4b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹4,750.10
7D
-5.7%
1Y
-29.8%
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 63.50
7D
-5.6%
1Y
-17.3%
Nanjing Vazyme Biotech
Market Cap: CN¥9.0b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥22.88
7D
3.4%
1Y
11.6%
Harbin Pharmaceutical Group
Market Cap: CN¥8.9b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥3.60
7D
-1.4%
1Y
5.6%
Evotec
Market Cap: €1.1b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€6.04
7D
-4.0%
1Y
-1.0%
Amphastar Pharmaceuticals
Market Cap: US$1.2b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$26.36
7D
-3.9%
1Y
-44.9%
Amoy Diagnostics
Market Cap: CN¥8.8b
Engages in the development and commercialization of diagnostics product for oncology in China and internationally.
300685
CN¥22.46
7D
-1.1%
1Y
10.6%
Kissei Pharmaceutical
Market Cap: JP¥184.4b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,455.00
7D
0.2%
1Y
24.8%
CureVac
Market Cap: US$1.2b
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$5.35
7D
0%
1Y
77.2%
Guilin Sanjin Pharmaceutical
Market Cap: CN¥8.6b
Engages in the research, production, and sale of traditional Chinese and natural medicines in China.
002275
CN¥14.55
7D
-0.4%
1Y
0.6%
Oscotec
Market Cap: ₩1.7t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩44,500.00
7D
2.5%
1Y
35.5%
Renhe PharmacyLtd
Market Cap: CN¥8.5b
Produces and sells pharmaceutical products.
000650
CN¥6.07
7D
-4.9%
1Y
2.9%
Innoviva
Market Cap: US$1.2b
Engages in the development and commercialization of pharmaceutical products in the United States and internationally.
INVA
US$18.57
7D
-6.6%
1Y
-2.0%
Guangxi Wuzhou Zhongheng Group
Market Cap: CN¥8.5b
Researches, develops, manufactures, and sells pharmaceuticals in China.
600252
CN¥2.65
7D
-6.4%
1Y
21.0%
Jiangsu Kanion PharmaceuticalLtd
Market Cap: CN¥8.5b
Researches and develops, produces, and sells Chinese medicines.
600557
CN¥15.03
7D
-2.5%
1Y
5.2%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥8.5b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥16.69
7D
-3.4%
1Y
-23.1%
Jiuzhitang
Market Cap: CN¥8.4b
Provides traditional Chinese, chemical, biological, and health medicine products in China.
000989
CN¥10.04
7D
-1.2%
1Y
43.8%
LENZ Therapeutics
Market Cap: US$1.2b
Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
LENZ
US$40.03
7D
-4.0%
1Y
79.9%